| 1 |
33630794 | Response to Concomitant Enzalutamide and 177Lu-PSMA-617 Radioligand Therapy in ATM-Mutated Metastatic Castration Resistant Prostate Cancer. | 2021 Jul 1 |
2 |
| 2 |
30657058 | N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway. | 2019 Jan 18 |
6 |
| 3 |
29439820 | Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide. | 2018 Aug |
1 |
| 4 |
28228262 | Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling. | 2017 Feb 21 |
1 |